For: | Uslusoy HS, Nak SG, Gülten M, Bıyıklı Z. Non-alcoholic steatohepatitis with normal aminotransferase values. World J Gastroenterol 2009; 15(15): 1863-1868 [PMID: 19370784 DOI: 10.3748/wjg.15.1863] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i15/1863.htm |
Number | Citing Articles |
1 |
Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-2
|
2 |
Elif Ozsu, Bahadır Yazıcıoğlu. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis. Hormones 2019; 18(4): 477 doi: 10.1007/s42000-019-00152-2
|
3 |
Tomonari Harada, Takeshi Araki, Hiroaki Sunaga, Kazuki Kagami, Kuniko Yoshida, Toshimitsu Kato, Ryo Kawakami, Junichi Tomono, Naoki Wada, Tatsuya Iso, Masahiko Kurabayashi, Masaru Obokata. Pathophysiological and diagnostic importance of fatty acid-binding protein 1 in heart failure with preserved ejection fraction. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00760-2
|
4 |
Ankush Jajodia, Philippe Soyer, Maxime Barat, Michael N. Patlas. Imaging of hepato-pancreato-biliary emergencies in patients with cancer. Diagnostic and Interventional Imaging 2024; 105(2): 47 doi: 10.1016/j.diii.2023.11.002
|
5 |
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova. Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity. Sechenov Medical Journal 2024; 15(2): 48 doi: 10.47093/2218-7332.2024.15.2.48-60
|
6 |
Qiaoli Huang, Xuying Tan, Qiongmei Wu, Hanqing Zhao, Hangjun Chen, Xinxue Yu, Jinting Wang, Xueyi Huang, Yurong Huang, Jun Wei, Feng Wu, Huilian Zhu, Lijun Wang. Lipid Accumulation Product is a Valid Predictor of Hepatic Steatosis and Nonalcoholic Fatty Liver Disease. Biomarkers in Medicine 2024; 18(3): 123 doi: 10.2217/bmm-2023-0725
|
7 |
Molly A. Bozic, Girish Subbarao, Jean P. Molleston. Pediatric Nonalcoholic Fatty Liver Disease. Nutrition in Clinical Practice 2013; 28(4): 448 doi: 10.1177/0884533613489153
|
8 |
Matthew D. Merrell, Nathan J. Cherrington. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metabolism Reviews 2011; 43(3): 317 doi: 10.3109/03602532.2011.577781
|
9 |
Ilona Darlyuk-Saadon, Chen Bai, Chew Kiat Matthew Heng, Nechama Gilad, Wei-Ping Yu, Pei Yen Lim, Amaury Cazenave-Gassiot, Yongliang Zhang, W. S. Fred Wong, David Engelberg. Active p38α causes macrovesicular fatty liver in mice. Proceedings of the National Academy of Sciences 2021; 118(14) doi: 10.1073/pnas.2018069118
|
10 |
Yoshiaki YAJIMA, Takako SUGITA, Taketoshi SATO, Takeru MITA, Mayumi TOZUKA, Isao KUROSAWA. Ultrasound findings of fatty liver using advanced ultrasonoscope equipped with differential tissue harmonic imaging: re-evaluation of diagnostic criteria in comparison with CT findings. Choonpa Igaku 2010; 37(5): 587 doi: 10.3179/jjmu.37.587
|
11 |
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care Physicians. Diabetes Technology & Therapeutics 2019; 21(11): 611 doi: 10.1089/dia.2019.0158
|
12 |
Diana Zaineff Banderas, Jorge Escobedo, Evangelina Gonzalez, María Gabriela Liceaga, Jesus Cenobio Ramírez, María Guadalupe Castro. γ-Glutamyl transferase. European Journal of Gastroenterology & Hepatology 2012; 24(7): 805 doi: 10.1097/MEG.0b013e328354044a
|
13 |
Jörn M. Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, Andreas Tietz, Stephane A. Regnier, Gorana Capkun, Qin Ye, Jürgen Loeffler, Marcos C. Pedrosa, Matt Docherty. NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32551-2
|
14 |
Adrian Bekier, Justyna Gatkowska, Maciej Chyb, Justyna Sokołowska, Grażyna Chwatko, Rafał Głowacki, Agata Paneth, Katarzyna Dzitko. 4-Arylthiosemicarbazide derivatives – Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo. European Journal of Medicinal Chemistry 2022; 244: 114812 doi: 10.1016/j.ejmech.2022.114812
|
15 |
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?. Alimentary Pharmacology & Therapeutics 2012; 36(9): 815 doi: 10.1111/apt.12046
|
16 |
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. Gastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
|
17 |
Nikhil S. Patil, Natasha Larocque, Christian B. van der Pol, Carlos Torres, Demetrios A. Raptis, Michael N. Patlas. Chemotherapy-Induced Toxicities: An Imaging Primer. Canadian Association of Radiologists Journal 2023; 74(2): 432 doi: 10.1177/08465371221120263
|
18 |
Walid A. Elsherbiny, Tarek A. Besheer, Amro A. El-Karef, Ehab B. Rakha. Prognostic factors for progression of simple steatosis to steatohepatitis in patients with persistent normal and elevated liver enzymes. Egyptian Liver Journal 2013; 3(4): 107 doi: 10.1097/01.ELX.0000433598.15423.a1
|
19 |
Ko Maung, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, Nelson J. Chao, Taewoong Choi, Anna Mae Diehl, Louis Diehl, Cristina Gasparetto, Mitchell Horwitz, Gwynn Douglas Long, Richard D. Lopez, David A. Rizzieri, Stefanie Sarantopoulos, Keith M. Sullivan, Mustafa R. Bashir, Anthony D. Sung, Gianfranco D. Alpini. Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLOS ONE 2020; 15(9): e0238824 doi: 10.1371/journal.pone.0238824
|
20 |
Edyta Maslak, Elzbieta Buczek, Antoni Szumny, Wojciech Szczepnski, Magdalena Franczyk-Zarow, Aneta Kopec, Stefan Chlopicki, Teresa Leszczynska, Renata B. Kostogrys. Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in Rats. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/535982
|
21 |
Sandhya Narasimhan, Kuppan Gokulakrishnan, Rangasamy Sampathkumar, Syed Farooq, Radhakrishnan Ravikumar, Viswanathan Mohan, Muthuswamy Balasubramanyam. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clinical Biochemistry 2010; 43(10-11): 815 doi: 10.1016/j.clinbiochem.2010.04.003
|
22 |
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard, Thomas D. Schiano. The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. Transplantation Proceedings 2021; 53(1): 159 doi: 10.1016/j.transproceed.2020.02.160
|
23 |
Behairy E. Behairy, Hatem M. Hussein, Elsayed I. Salama, Nermin M. Adawy, Ashraf A. Elmeery. Nonalcoholic fatty liver and steatohepatitis in obese children. Egyptian Liver Journal 2011; 1(2): 73 doi: 10.1097/01.ELX.0000397037.56165.75
|
24 |
Emily R. Perito, Patrika M. Tsai, Sarah Hawley, Robert H. Lustig, Vickie A. Feldstein. Targeted Hepatic Sonography During Clinic Visits for Detection of Fatty Liver in Overweight Children. Journal of Ultrasound in Medicine 2013; 32(4): 637 doi: 10.7863/jum.2013.32.4.637
|
25 |
Mario Masarone, Valerio Rosato, Andrea Aglitti, Tommaso Bucci, Rosa Caruso, Teresa Salvatore, Ferdinando Carlo Sasso, Marie Francoise Tripodi, Marcello Persico, Patricia Aspichueta. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PLOS ONE 2017; 12(6): e0178473 doi: 10.1371/journal.pone.0178473
|
26 |
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
|
27 |
Yusuf Yilmaz, Enver Dolar. Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: Tools or decorations?. World Journal of Gastroenterology 2009; 15(34): 4346-4347 doi: 10.3748/wjg.15.4346
|
28 |
Katelynn S. Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, Michał Ciszek, Magdalena Durlik, Sandy Feng, Bartosz Foroncewicz, Iman Francis, Michał Grąt, Krzysztof Jurczyk, Goran Klintmalm, Maciej Krasnodębski, Geoff McCaughan, Rosa Miquel, Aldo Montano-Loza, Dilip Moonka, Krzysztof Mucha, Marek Myślak, Leszek Pączek, Agnieszka Perkowska-Ptasińska, Grzegorz Piecha, Trevor Reichman, Alberto Sanchez-Fueyo, Olga Tronina, Marta Wawrzynowicz-Syczewska, Andrzej Więcek, Krzysztof Zieniewicz, Philip F. Halloran. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. American Journal of Transplantation 2022; 22(3): 909 doi: 10.1111/ajt.16890
|
29 |
Josivan G. Lima, Lucia Helena C. Nobrega, Natalia Nobrega de Lima, Maria Goretti do Nascimento Santos, Maria F. P. Baracho, Selma Maria Bezerra Jeronimo. Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy. Diabetology & Metabolic Syndrome 2016; 8(1) doi: 10.1186/s13098-016-0140-x
|
30 |
Federica Vernuccio, Marco Dioguardi Burgio, Filippo Barbiera, Silvestro Cusmà, Giuseppe Badalamenti, Massimo Midiri, Valérie Vilgrain, Giuseppe Brancatelli. CT and MR imaging of chemotherapy-induced hepatopathy. Abdominal Radiology 2019; 44(10): 3312 doi: 10.1007/s00261-019-02193-y
|
31 |
Karuna Rasineni, Daniel D. Penrice, Sathish Kumar Natarajan, Mark A. McNiven, Benita L. McVicker, Kusum K. Kharbanda, Carol A. Casey, Edward N. Harris. Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0433-4
|
32 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
|
33 |
Hiroyuki Kanamori, Yukiomi Nakade, Taeko Yamauchi, Kazumasa Sakamoto, Tadahisa Inoue, Takaya Yamamoto, Yuji Kobayashi, Norimitsu Ishii, Tomohiko Ohashi, Kiyoaki Ito, Yoshio Sumida, Haruhisa Nakao, Yoshitaka Fukuzawa, Masashi Yoneda, Pavel Strnad. Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats. PLOS ONE 2017; 12(6): e0180475 doi: 10.1371/journal.pone.0180475
|
34 |
Alyaa Abusabeib, Walid El Ansari, Jassim Alobaidan, Wahiba Elhag. First Case Report of Fulminant Hepatitis After Laparoscopic Sleeve Gastrectomy Associated with Concomitant Maximal Therapeutic Dose of Acetaminophen Use, Protein Calorie Malnutrition, and Vitamins A and D, Selenium, and Glutathione Deficiencies. Obesity Surgery 2021; 31(2): 899 doi: 10.1007/s11695-020-04999-y
|
35 |
Safiye Mirzaii, Marjan Mansourian, Seyedeh-Masomeh Derakhshandeh-Rishehri, Roya Kelishadi, Motahar Heidari-Beni. Association of conjugated linoleic acid consumption and liver enzymes in human studies: A systematic review and meta-analysis of randomized controlled clinical trials. Nutrition 2016; 32(2): 166 doi: 10.1016/j.nut.2015.08.013
|
36 |
Shunsuke Mori, Nobuyuki Arima, Masahiro Ito, Shigetoshi Fujiyama, Yasuhiro Kamo, Yukitaka Ueki, Pavel Strnad. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment. PLOS ONE 2018; 13(8): e0203084 doi: 10.1371/journal.pone.0203084
|
37 |
Katherine J.P. Schwenger, Alexander Kiu, Maryam AlAli, Amnah Alhanaee, Sandra E. Fischer, Johane P. Allard. Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. Nutrition 2022; 93: 111491 doi: 10.1016/j.nut.2021.111491
|
38 |
M. V. Kruchinina, M. F. Osipenko, M. V. Parulikova, A. A. Gromov. Electrical and Viscoelastic Parameters of Erythrocytes as a Part of Diagnostic Models for Differentiating Fatty Liver Disease of Mixed Genesis from Non-Alcoholic and Alcohol-Related Fatty Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(3): 38 doi: 10.22416/1382-4376-2024-1215-3218
|
39 |
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
|
40 |
Xuefeng Ma, Shousheng Liu, Jie Zhang, Mengzhen Dong, Yifen Wang, Mengke Wang, Yongning Xin. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1165-z
|
41 |
Zeinab A. Elkabbany, Nancy S. Elbarbary, Eman A. Ismail, Nesrine A. Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M. Ezzat, Sarah S. Maurice, Noha U. Hashem. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. Journal of Diabetes and its Complications 2017; 31(1): 186 doi: 10.1016/j.jdiacomp.2016.09.009
|
42 |
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?. Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
|
43 |
AssimA Alfadda, SuphiaM Sherbeeni, AdelN Alqutub, AbdullahS Aldosary, NasserM Aldaghri, SimonD Taylor-Robinson, SalehA Alqahtani, Rukhsana Gul, AbdulrahmanM Almaghamsi. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study. Saudi Journal of Gastroenterology 2022; 28(6): 426 doi: 10.4103/sjg.sjg_73_22
|
44 |
R Christopher Harmon, Dina G Tiniakos, Curtis K Argo. Inflammation in nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2011; 5(2): 189 doi: 10.1586/egh.11.21
|
45 |
Y. Sumida, T. Yoshikawa, S. Tanaka, H. Taketani, K. Kanemasa, T. Nishimura, K. Yamaguchi, H. Mitsuyoshi, K. Yasui, M. Minami, Y. Naito, Y. Itoh. The 'donations for decreased ALT (D4D)' prosocial behavior incentive scheme for NAFLD patients. Journal of Public Health 2014; 36(4): 629 doi: 10.1093/pubmed/fdt098
|
46 |
Peter Makovicky, Eva Tumova, Zdenek Volek, Pavol Makovicky, Ludmila Vodickova, Jana Slyskova, Miroslav Svoboda, Alexandra Rejhova, Pavel Vodicka, Gabriel Samasca, Alena Kralova, Melinda Nagy, Marta Mydlarova-Blascakova, Jana Poracova. Histopathological aspects of liver under variable food restriction: Has the intense one-week food restriction a protective effect on non-alcoholic-fatty-liver-disease (NAFLD) development?. Pathology - Research and Practice 2014; 210(12): 855 doi: 10.1016/j.prp.2014.08.007
|
47 |
Renata B. Kostogrys, Magdalena Franczyk-Żarów, Edyta Maślak, Kinga Topolska. Effect of low carbohydrate high protein (LCHP) diet on lipid metabolism, liver and kidney function in rats. Environmental Toxicology and Pharmacology 2015; 39(2): 713 doi: 10.1016/j.etap.2015.01.008
|
48 |
Yoshio Sumida, Yuichiro Eguchi, Masafumi Ono. Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan. World Journal of Hepatology 2010; 2(10): 374-383 doi: 10.4254/wjh.v2.i10.374
|
49 |
O. J. Kolawole, M. M. Oje, O. A. Betiku, O. Ijarotimi, O. Adekanle, D. A. Ndububa. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03237-4
|
50 |
Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day. Non‐Alcoholic Fatty Liver Disease. 2013; : 1 doi: 10.1002/9781118556153.ch1
|
51 |
Huseyin Korkmaz, Gülhan K. Unler, Huseyin S. Gokturk, Wolfgang E. Schmidt, Levent Kebapcilar. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. European Journal of Gastroenterology & Hepatology 2015; 27(10): 1137 doi: 10.1097/MEG.0000000000000407
|